nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C19—Memantine—Alzheimer's disease	0.133	0.382	CbGbCtD
Lapatinib—CYP3A4—Rivastigmine—Alzheimer's disease	0.0927	0.267	CbGbCtD
Lapatinib—CYP3A4—Donepezil—Alzheimer's disease	0.0741	0.213	CbGbCtD
Lapatinib—CYP3A4—Galantamine—Alzheimer's disease	0.0478	0.137	CbGbCtD
Lapatinib—PIK3C2B—telencephalon—Alzheimer's disease	0.00686	0.0633	CbGeAlD
Lapatinib—ERBB2—embryo—Alzheimer's disease	0.00656	0.0605	CbGeAlD
Lapatinib—ERBB4—embryo—Alzheimer's disease	0.00656	0.0605	CbGeAlD
Lapatinib—ERBB4—forebrain—Alzheimer's disease	0.0058	0.0535	CbGeAlD
Lapatinib—ERBB4—telencephalon—Alzheimer's disease	0.00534	0.0492	CbGeAlD
Lapatinib—PI4KB—telencephalon—Alzheimer's disease	0.005	0.0461	CbGeAlD
Lapatinib—EGFR—telencephalon—Alzheimer's disease	0.00452	0.0417	CbGeAlD
Lapatinib—Nail disorder—Rivastigmine—Alzheimer's disease	0.00406	0.0172	CcSEcCtD
Lapatinib—TAP1—cerebellum—Alzheimer's disease	0.00406	0.0375	CbGeAlD
Lapatinib—PIK3C2B—nervous system—Alzheimer's disease	0.00405	0.0374	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—Alzheimer's disease	0.0039	0.036	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—Alzheimer's disease	0.00381	0.0352	CbGeAlD
Lapatinib—TAP1—brain—Alzheimer's disease	0.0033	0.0304	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Donepezil—Alzheimer's disease	0.00326	0.0138	CcSEcCtD
Lapatinib—ERBB2—nervous system—Alzheimer's disease	0.00315	0.0291	CbGeAlD
Lapatinib—ERBB4—nervous system—Alzheimer's disease	0.00315	0.0291	CbGeAlD
Lapatinib—PIK3C2B—brain—Alzheimer's disease	0.0031	0.0286	CbGeAlD
Lapatinib—Neoplasm malignant—Rivastigmine—Alzheimer's disease	0.00308	0.0131	CcSEcCtD
Lapatinib—ERBB2—central nervous system—Alzheimer's disease	0.00303	0.028	CbGeAlD
Lapatinib—ERBB4—central nervous system—Alzheimer's disease	0.00303	0.028	CbGeAlD
Lapatinib—ERBB2—cerebellum—Alzheimer's disease	0.00296	0.0274	CbGeAlD
Lapatinib—ERBB4—cerebellum—Alzheimer's disease	0.00296	0.0274	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Memantine—Alzheimer's disease	0.00296	0.0125	CcSEcCtD
Lapatinib—PI4KB—nervous system—Alzheimer's disease	0.00295	0.0272	CbGeAlD
Lapatinib—Cardiac failure—Galantamine—Alzheimer's disease	0.00284	0.0121	CcSEcCtD
Lapatinib—PI4KB—central nervous system—Alzheimer's disease	0.00284	0.0262	CbGeAlD
Lapatinib—Pain in extremity—Galantamine—Alzheimer's disease	0.00278	0.0118	CcSEcCtD
Lapatinib—PI4KB—cerebellum—Alzheimer's disease	0.00278	0.0256	CbGeAlD
Lapatinib—Dehydration—Galantamine—Alzheimer's disease	0.00258	0.0109	CcSEcCtD
Lapatinib—EGFR—cerebellum—Alzheimer's disease	0.00251	0.0232	CbGeAlD
Lapatinib—ERBB2—brain—Alzheimer's disease	0.00241	0.0222	CbGeAlD
Lapatinib—ERBB4—brain—Alzheimer's disease	0.00241	0.0222	CbGeAlD
Lapatinib—Hot flush—Donepezil—Alzheimer's disease	0.0023	0.00975	CcSEcCtD
Lapatinib—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00228	0.00966	CcSEcCtD
Lapatinib—PI4KB—brain—Alzheimer's disease	0.00225	0.0208	CbGeAlD
Lapatinib—Cardiac failure—Donepezil—Alzheimer's disease	0.0022	0.00934	CcSEcCtD
Lapatinib—Pneumonia—Galantamine—Alzheimer's disease	0.00215	0.00912	CcSEcCtD
Lapatinib—Renal failure acute—Memantine—Alzheimer's disease	0.00212	0.00897	CcSEcCtD
Lapatinib—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.0021	0.00889	CcSEcCtD
Lapatinib—Hot flush—Memantine—Alzheimer's disease	0.00209	0.00885	CcSEcCtD
Lapatinib—Menopausal symptoms—Memantine—Alzheimer's disease	0.00207	0.00877	CcSEcCtD
Lapatinib—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00207	0.00877	CcSEcCtD
Lapatinib—Hot flush—Rivastigmine—Alzheimer's disease	0.00204	0.00866	CcSEcCtD
Lapatinib—EGFR—brain—Alzheimer's disease	0.00204	0.0188	CbGeAlD
Lapatinib—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00203	0.00858	CcSEcCtD
Lapatinib—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00202	0.00858	CcSEcCtD
Lapatinib—Epistaxis—Galantamine—Alzheimer's disease	0.00202	0.00855	CcSEcCtD
Lapatinib—Cardiac failure—Memantine—Alzheimer's disease	0.002	0.00848	CcSEcCtD
Lapatinib—Dehydration—Donepezil—Alzheimer's disease	0.002	0.00848	CcSEcCtD
Lapatinib—Dry skin—Donepezil—Alzheimer's disease	0.00197	0.00836	CcSEcCtD
Lapatinib—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00196	0.0083	CcSEcCtD
Lapatinib—Pain in extremity—Memantine—Alzheimer's disease	0.00195	0.00828	CcSEcCtD
Lapatinib—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00191	0.0081	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.0019	0.00804	CcSEcCtD
Lapatinib—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00189	0.008	CcSEcCtD
Lapatinib—Dehydration—Memantine—Alzheimer's disease	0.00182	0.0077	CcSEcCtD
Lapatinib—Dry skin—Memantine—Alzheimer's disease	0.00179	0.00759	CcSEcCtD
Lapatinib—Cardiac disorder—Galantamine—Alzheimer's disease	0.00178	0.00755	CcSEcCtD
Lapatinib—Dehydration—Rivastigmine—Alzheimer's disease	0.00178	0.00753	CcSEcCtD
Lapatinib—Dry skin—Rivastigmine—Alzheimer's disease	0.00175	0.00742	CcSEcCtD
Lapatinib—Angiopathy—Galantamine—Alzheimer's disease	0.00174	0.00739	CcSEcCtD
Lapatinib—Immune system disorder—Galantamine—Alzheimer's disease	0.00173	0.00735	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00172	0.0073	CcSEcCtD
Lapatinib—Mental disorder—Galantamine—Alzheimer's disease	0.00168	0.00713	CcSEcCtD
Lapatinib—Malnutrition—Galantamine—Alzheimer's disease	0.00167	0.00709	CcSEcCtD
Lapatinib—Pneumonia—Donepezil—Alzheimer's disease	0.00167	0.00707	CcSEcCtD
Lapatinib—Infestation—Donepezil—Alzheimer's disease	0.00166	0.00703	CcSEcCtD
Lapatinib—Infestation NOS—Donepezil—Alzheimer's disease	0.00166	0.00703	CcSEcCtD
Lapatinib—Back pain—Galantamine—Alzheimer's disease	0.00162	0.00685	CcSEcCtD
Lapatinib—Neutropenia—Memantine—Alzheimer's disease	0.00158	0.00669	CcSEcCtD
Lapatinib—Epistaxis—Donepezil—Alzheimer's disease	0.00156	0.00663	CcSEcCtD
Lapatinib—Anaemia—Galantamine—Alzheimer's disease	0.00155	0.00655	CcSEcCtD
Lapatinib—Pneumonia—Memantine—Alzheimer's disease	0.00151	0.00642	CcSEcCtD
Lapatinib—Infestation—Memantine—Alzheimer's disease	0.00151	0.00638	CcSEcCtD
Lapatinib—Infestation NOS—Memantine—Alzheimer's disease	0.00151	0.00638	CcSEcCtD
Lapatinib—Pneumonia—Rivastigmine—Alzheimer's disease	0.00148	0.00628	CcSEcCtD
Lapatinib—Palpitations—Galantamine—Alzheimer's disease	0.00148	0.00626	CcSEcCtD
Lapatinib—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00148	0.00625	CcSEcCtD
Lapatinib—Infestation—Rivastigmine—Alzheimer's disease	0.00147	0.00624	CcSEcCtD
Lapatinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00147	0.00624	CcSEcCtD
Lapatinib—Cough—Galantamine—Alzheimer's disease	0.00146	0.00618	CcSEcCtD
Lapatinib—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00144	0.00612	CcSEcCtD
Lapatinib—ABCB1—blood vessel—Alzheimer's disease	0.00143	0.0132	CbGeAlD
Lapatinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00142	0.00603	CcSEcCtD
Lapatinib—Arthralgia—Galantamine—Alzheimer's disease	0.00142	0.00603	CcSEcCtD
Lapatinib—Myalgia—Galantamine—Alzheimer's disease	0.00142	0.00603	CcSEcCtD
Lapatinib—Epistaxis—Memantine—Alzheimer's disease	0.00142	0.00602	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00141	0.00599	CcSEcCtD
Lapatinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00139	0.0059	CcSEcCtD
Lapatinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.00139	0.00589	CcSEcCtD
Lapatinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.00134	0.00567	CcSEcCtD
Lapatinib—Connective tissue disorder—Memantine—Alzheimer's disease	0.00133	0.00563	CcSEcCtD
Lapatinib—Skin disorder—Galantamine—Alzheimer's disease	0.00133	0.00562	CcSEcCtD
Lapatinib—Alopecia—Donepezil—Alzheimer's disease	0.00132	0.00557	CcSEcCtD
Lapatinib—Mental disorder—Donepezil—Alzheimer's disease	0.0013	0.00553	CcSEcCtD
Lapatinib—Anorexia—Galantamine—Alzheimer's disease	0.0013	0.00551	CcSEcCtD
Lapatinib—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.0013	0.00551	CcSEcCtD
Lapatinib—Malnutrition—Donepezil—Alzheimer's disease	0.0013	0.00549	CcSEcCtD
Lapatinib—Cardiac disorder—Memantine—Alzheimer's disease	0.00125	0.00532	CcSEcCtD
Lapatinib—Back pain—Donepezil—Alzheimer's disease	0.00125	0.00531	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00124	0.00527	CcSEcCtD
Lapatinib—Insomnia—Galantamine—Alzheimer's disease	0.00123	0.00523	CcSEcCtD
Lapatinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00123	0.0052	CcSEcCtD
Lapatinib—Angiopathy—Memantine—Alzheimer's disease	0.00123	0.0052	CcSEcCtD
Lapatinib—Immune system disorder—Memantine—Alzheimer's disease	0.00122	0.00517	CcSEcCtD
Lapatinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.00122	0.00516	CcSEcCtD
Lapatinib—Dyspepsia—Galantamine—Alzheimer's disease	0.0012	0.00509	CcSEcCtD
Lapatinib—Angiopathy—Rivastigmine—Alzheimer's disease	0.0012	0.00508	CcSEcCtD
Lapatinib—Anaemia—Donepezil—Alzheimer's disease	0.0012	0.00508	CcSEcCtD
Lapatinib—Alopecia—Memantine—Alzheimer's disease	0.00119	0.00506	CcSEcCtD
Lapatinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00119	0.00505	CcSEcCtD
Lapatinib—Decreased appetite—Galantamine—Alzheimer's disease	0.00119	0.00503	CcSEcCtD
Lapatinib—Mental disorder—Memantine—Alzheimer's disease	0.00118	0.00502	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00118	0.00499	CcSEcCtD
Lapatinib—Malnutrition—Memantine—Alzheimer's disease	0.00118	0.00499	CcSEcCtD
Lapatinib—Fatigue—Galantamine—Alzheimer's disease	0.00118	0.00499	CcSEcCtD
Lapatinib—Alopecia—Rivastigmine—Alzheimer's disease	0.00117	0.00495	CcSEcCtD
Lapatinib—Constipation—Galantamine—Alzheimer's disease	0.00117	0.00495	CcSEcCtD
Lapatinib—Mental disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00491	CcSEcCtD
Lapatinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.00115	0.00488	CcSEcCtD
Lapatinib—Back pain—Memantine—Alzheimer's disease	0.00114	0.00482	CcSEcCtD
Lapatinib—Cough—Donepezil—Alzheimer's disease	0.00113	0.00479	CcSEcCtD
Lapatinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00112	0.00473	CcSEcCtD
Lapatinib—Back pain—Rivastigmine—Alzheimer's disease	0.00111	0.00472	CcSEcCtD
Lapatinib—Myalgia—Donepezil—Alzheimer's disease	0.0011	0.00468	CcSEcCtD
Lapatinib—Arthralgia—Donepezil—Alzheimer's disease	0.0011	0.00468	CcSEcCtD
Lapatinib—Anaemia—Memantine—Alzheimer's disease	0.00109	0.00461	CcSEcCtD
Lapatinib—Abdominal pain—Galantamine—Alzheimer's disease	0.00108	0.00457	CcSEcCtD
Lapatinib—Anaemia—Rivastigmine—Alzheimer's disease	0.00106	0.00451	CcSEcCtD
Lapatinib—Leukopenia—Memantine—Alzheimer's disease	0.00105	0.00446	CcSEcCtD
Lapatinib—Infection—Donepezil—Alzheimer's disease	0.00105	0.00445	CcSEcCtD
Lapatinib—Palpitations—Memantine—Alzheimer's disease	0.00104	0.00441	CcSEcCtD
Lapatinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.00104	0.0044	CcSEcCtD
Lapatinib—Cough—Memantine—Alzheimer's disease	0.00103	0.00435	CcSEcCtD
Lapatinib—Palpitations—Rivastigmine—Alzheimer's disease	0.00102	0.00431	CcSEcCtD
Lapatinib—Anorexia—Donepezil—Alzheimer's disease	0.00101	0.00427	CcSEcCtD
Lapatinib—Hypersensitivity—Galantamine—Alzheimer's disease	0.00101	0.00426	CcSEcCtD
Lapatinib—Cough—Rivastigmine—Alzheimer's disease	0.001	0.00426	CcSEcCtD
Lapatinib—Myalgia—Memantine—Alzheimer's disease	0.001	0.00424	CcSEcCtD
Lapatinib—Arthralgia—Memantine—Alzheimer's disease	0.001	0.00424	CcSEcCtD
Lapatinib—Myalgia—Rivastigmine—Alzheimer's disease	0.00098	0.00415	CcSEcCtD
Lapatinib—Arthralgia—Rivastigmine—Alzheimer's disease	0.00098	0.00415	CcSEcCtD
Lapatinib—Asthenia—Galantamine—Alzheimer's disease	0.000979	0.00415	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000973	0.00412	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000963	0.00408	CcSEcCtD
Lapatinib—Insomnia—Donepezil—Alzheimer's disease	0.000956	0.00405	CcSEcCtD
Lapatinib—Infection—Memantine—Alzheimer's disease	0.000954	0.00404	CcSEcCtD
Lapatinib—Dyspnoea—Donepezil—Alzheimer's disease	0.000943	0.004	CcSEcCtD
Lapatinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000942	0.00399	CcSEcCtD
Lapatinib—Diarrhoea—Galantamine—Alzheimer's disease	0.000934	0.00396	CcSEcCtD
Lapatinib—Infection—Rivastigmine—Alzheimer's disease	0.000933	0.00395	CcSEcCtD
Lapatinib—Skin disorder—Memantine—Alzheimer's disease	0.000933	0.00395	CcSEcCtD
Lapatinib—Dyspepsia—Donepezil—Alzheimer's disease	0.000931	0.00395	CcSEcCtD
Lapatinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000921	0.0039	CcSEcCtD
Lapatinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000919	0.0039	CcSEcCtD
Lapatinib—Anorexia—Memantine—Alzheimer's disease	0.000915	0.00388	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000913	0.00387	CcSEcCtD
Lapatinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000912	0.00387	CcSEcCtD
Lapatinib—Fatigue—Donepezil—Alzheimer's disease	0.000912	0.00386	CcSEcCtD
Lapatinib—Constipation—Donepezil—Alzheimer's disease	0.000904	0.00383	CcSEcCtD
Lapatinib—Anorexia—Rivastigmine—Alzheimer's disease	0.000895	0.00379	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000875	0.00371	CcSEcCtD
Lapatinib—Insomnia—Memantine—Alzheimer's disease	0.000868	0.00368	CcSEcCtD
Lapatinib—Vomiting—Galantamine—Alzheimer's disease	0.000868	0.00368	CcSEcCtD
Lapatinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000865	0.00366	CcSEcCtD
Lapatinib—Rash—Galantamine—Alzheimer's disease	0.00086	0.00365	CcSEcCtD
Lapatinib—Dermatitis—Galantamine—Alzheimer's disease	0.00086	0.00364	CcSEcCtD
Lapatinib—Dyspnoea—Memantine—Alzheimer's disease	0.000856	0.00363	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000856	0.00363	CcSEcCtD
Lapatinib—Headache—Galantamine—Alzheimer's disease	0.000855	0.00362	CcSEcCtD
Lapatinib—ABCB1—embryo—Alzheimer's disease	0.000855	0.00789	CbGeAlD
Lapatinib—Insomnia—Rivastigmine—Alzheimer's disease	0.00085	0.0036	CcSEcCtD
Lapatinib—Dyspepsia—Memantine—Alzheimer's disease	0.000845	0.00358	CcSEcCtD
Lapatinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000837	0.00355	CcSEcCtD
Lapatinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000836	0.00354	CcSEcCtD
Lapatinib—Decreased appetite—Memantine—Alzheimer's disease	0.000835	0.00354	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000829	0.00351	CcSEcCtD
Lapatinib—Fatigue—Memantine—Alzheimer's disease	0.000828	0.00351	CcSEcCtD
Lapatinib—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000827	0.0035	CcSEcCtD
Lapatinib—Constipation—Memantine—Alzheimer's disease	0.000821	0.00348	CcSEcCtD
Lapatinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000817	0.00346	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000811	0.00344	CcSEcCtD
Lapatinib—Nausea—Galantamine—Alzheimer's disease	0.000811	0.00344	CcSEcCtD
Lapatinib—Fatigue—Rivastigmine—Alzheimer's disease	0.00081	0.00343	CcSEcCtD
Lapatinib—Constipation—Rivastigmine—Alzheimer's disease	0.000803	0.0034	CcSEcCtD
Lapatinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000785	0.00333	CcSEcCtD
Lapatinib—Hypersensitivity—Donepezil—Alzheimer's disease	0.000779	0.0033	CcSEcCtD
Lapatinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000768	0.00326	CcSEcCtD
Lapatinib—Abdominal pain—Memantine—Alzheimer's disease	0.000759	0.00322	CcSEcCtD
Lapatinib—Asthenia—Donepezil—Alzheimer's disease	0.000759	0.00322	CcSEcCtD
Lapatinib—ABCB1—forebrain—Alzheimer's disease	0.000756	0.00698	CbGeAlD
Lapatinib—Pruritus—Donepezil—Alzheimer's disease	0.000748	0.00317	CcSEcCtD
Lapatinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000743	0.00315	CcSEcCtD
Lapatinib—Diarrhoea—Donepezil—Alzheimer's disease	0.000724	0.00307	CcSEcCtD
Lapatinib—Hypersensitivity—Memantine—Alzheimer's disease	0.000707	0.003	CcSEcCtD
Lapatinib—ABCB1—telencephalon—Alzheimer's disease	0.000695	0.00641	CbGeAlD
Lapatinib—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000692	0.00293	CcSEcCtD
Lapatinib—Asthenia—Memantine—Alzheimer's disease	0.000689	0.00292	CcSEcCtD
Lapatinib—Pruritus—Memantine—Alzheimer's disease	0.000679	0.00288	CcSEcCtD
Lapatinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000674	0.00286	CcSEcCtD
Lapatinib—Vomiting—Donepezil—Alzheimer's disease	0.000672	0.00285	CcSEcCtD
Lapatinib—Rash—Donepezil—Alzheimer's disease	0.000667	0.00283	CcSEcCtD
Lapatinib—Dermatitis—Donepezil—Alzheimer's disease	0.000666	0.00282	CcSEcCtD
Lapatinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000665	0.00282	CcSEcCtD
Lapatinib—Headache—Donepezil—Alzheimer's disease	0.000663	0.00281	CcSEcCtD
Lapatinib—Diarrhoea—Memantine—Alzheimer's disease	0.000657	0.00278	CcSEcCtD
Lapatinib—CYP2C8—brain—Alzheimer's disease	0.000654	0.00604	CbGeAlD
Lapatinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000643	0.00272	CcSEcCtD
Lapatinib—Nausea—Donepezil—Alzheimer's disease	0.000628	0.00266	CcSEcCtD
Lapatinib—Vomiting—Memantine—Alzheimer's disease	0.000611	0.00259	CcSEcCtD
Lapatinib—Rash—Memantine—Alzheimer's disease	0.000605	0.00257	CcSEcCtD
Lapatinib—Dermatitis—Memantine—Alzheimer's disease	0.000605	0.00256	CcSEcCtD
Lapatinib—Headache—Memantine—Alzheimer's disease	0.000602	0.00255	CcSEcCtD
Lapatinib—Vomiting—Rivastigmine—Alzheimer's disease	0.000597	0.00253	CcSEcCtD
Lapatinib—Rash—Rivastigmine—Alzheimer's disease	0.000592	0.00251	CcSEcCtD
Lapatinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000592	0.00251	CcSEcCtD
Lapatinib—Headache—Rivastigmine—Alzheimer's disease	0.000588	0.00249	CcSEcCtD
Lapatinib—CYP3A4—nervous system—Alzheimer's disease	0.00058	0.00535	CbGeAlD
Lapatinib—Nausea—Memantine—Alzheimer's disease	0.00057	0.00242	CcSEcCtD
Lapatinib—CYP3A4—central nervous system—Alzheimer's disease	0.000558	0.00515	CbGeAlD
Lapatinib—Nausea—Rivastigmine—Alzheimer's disease	0.000558	0.00236	CcSEcCtD
Lapatinib—ABCB1—nervous system—Alzheimer's disease	0.00041	0.00379	CbGeAlD
Lapatinib—ABCB1—central nervous system—Alzheimer's disease	0.000395	0.00365	CbGeAlD
Lapatinib—ABCB1—cerebellum—Alzheimer's disease	0.000386	0.00356	CbGeAlD
Lapatinib—ABCB1—brain—Alzheimer's disease	0.000314	0.00289	CbGeAlD
Lapatinib—ERBB4—Signaling Pathways—INS—Alzheimer's disease	1.96e-05	6.37e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCL2—Alzheimer's disease	1.96e-05	6.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—Alzheimer's disease	1.96e-05	6.36e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCL2—Alzheimer's disease	1.93e-05	6.27e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IGF1—Alzheimer's disease	1.93e-05	6.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SST—Alzheimer's disease	1.92e-05	6.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GAB2—Alzheimer's disease	1.92e-05	6.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NTRK2—Alzheimer's disease	1.92e-05	6.24e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.92e-05	6.24e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.92e-05	6.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—LPL—Alzheimer's disease	1.92e-05	6.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CALM1—Alzheimer's disease	1.92e-05	6.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GSK3A—Alzheimer's disease	1.91e-05	6.19e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IGF1—Alzheimer's disease	1.9e-05	6.16e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.9e-05	6.15e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.88e-05	6.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APP—Alzheimer's disease	1.88e-05	6.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.87e-05	6.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PRKCG—Alzheimer's disease	1.87e-05	6.06e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.84e-05	5.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—Alzheimer's disease	1.83e-05	5.94e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.81e-05	5.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—AKT1—Alzheimer's disease	1.81e-05	5.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—F2—Alzheimer's disease	1.8e-05	5.84e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.8e-05	5.83e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.78e-05	5.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—Alzheimer's disease	1.77e-05	5.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CCR5—Alzheimer's disease	1.77e-05	5.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PLCB1—Alzheimer's disease	1.77e-05	5.74e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.76e-05	5.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MAPK8—Alzheimer's disease	1.75e-05	5.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CALM1—Alzheimer's disease	1.75e-05	5.68e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOS3—Alzheimer's disease	1.75e-05	5.67e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.74e-05	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MTHFR—Alzheimer's disease	1.73e-05	5.61e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.72e-05	5.59e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOS3—Alzheimer's disease	1.72e-05	5.59e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.72e-05	5.59e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.72e-05	5.57e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.72e-05	5.57e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.71e-05	5.56e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.7e-05	5.52e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.69e-05	5.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—Alzheimer's disease	1.68e-05	5.45e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.68e-05	5.44e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.68e-05	5.44e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.66e-05	5.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGFR—Alzheimer's disease	1.65e-05	5.36e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—Alzheimer's disease	1.65e-05	5.36e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.65e-05	5.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CREB1—Alzheimer's disease	1.64e-05	5.32e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—Alzheimer's disease	1.63e-05	5.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CALM1—Alzheimer's disease	1.62e-05	5.25e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.61e-05	5.24e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.61e-05	5.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADAM10—Alzheimer's disease	1.61e-05	5.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—APOE—Alzheimer's disease	1.61e-05	5.23e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.61e-05	5.21e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL2—Alzheimer's disease	1.61e-05	5.21e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.6e-05	5.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CAV1—Alzheimer's disease	1.6e-05	5.18e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.58e-05	5.14e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	1.58e-05	5.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—Alzheimer's disease	1.57e-05	5.09e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.57e-05	5.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.55e-05	5.04e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.55e-05	5.02e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.53e-05	4.97e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.53e-05	4.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—S100B—Alzheimer's disease	1.52e-05	4.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—GSK3B—Alzheimer's disease	1.51e-05	4.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS2—Alzheimer's disease	1.5e-05	4.87e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.5e-05	4.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CREB1—Alzheimer's disease	1.5e-05	4.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—A2M—Alzheimer's disease	1.49e-05	4.85e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.49e-05	4.85e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.49e-05	4.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOTCH1—Alzheimer's disease	1.49e-05	4.82e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CASP3—Alzheimer's disease	1.48e-05	4.82e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.47e-05	4.78e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CASP3—Alzheimer's disease	1.46e-05	4.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF2—Alzheimer's disease	1.45e-05	4.71e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.42e-05	4.59e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1R—Alzheimer's disease	1.4e-05	4.55e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.4e-05	4.53e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.4e-05	4.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—GSK3B—Alzheimer's disease	1.4e-05	4.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CREB1—Alzheimer's disease	1.38e-05	4.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—INS—Alzheimer's disease	1.38e-05	4.47e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.37e-05	4.45e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.37e-05	4.45e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.36e-05	4.43e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK8—Alzheimer's disease	1.36e-05	4.43e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—Alzheimer's disease	1.35e-05	4.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LPL—Alzheimer's disease	1.35e-05	4.37e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK8—Alzheimer's disease	1.34e-05	4.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MEF2C—Alzheimer's disease	1.33e-05	4.33e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ACHE—Alzheimer's disease	1.33e-05	4.32e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—Alzheimer's disease	1.33e-05	4.31e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	1.32e-05	4.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCG—Alzheimer's disease	1.31e-05	4.25e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.3e-05	4.22e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.3e-05	4.22e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.28e-05	4.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NGF—Alzheimer's disease	1.27e-05	4.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—Alzheimer's disease	1.27e-05	4.11e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.26e-05	4.09e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-05	4.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—BCL2—Alzheimer's disease	1.26e-05	4.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ENO1—Alzheimer's disease	1.25e-05	4.05e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	1.25e-05	4.05e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—Alzheimer's disease	1.24e-05	4.04e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—Alzheimer's disease	1.24e-05	4.03e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—Alzheimer's disease	1.24e-05	4.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—Alzheimer's disease	1.24e-05	4.02e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	1.23e-05	3.98e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—Alzheimer's disease	1.23e-05	3.98e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—Alzheimer's disease	1.22e-05	3.97e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	1.22e-05	3.97e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.22e-05	3.95e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.22e-05	3.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HTR2A—Alzheimer's disease	1.21e-05	3.94e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—Alzheimer's disease	1.21e-05	3.92e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.2e-05	3.9e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.19e-05	3.87e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	1.19e-05	3.86e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.18e-05	3.84e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.18e-05	3.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—Alzheimer's disease	1.17e-05	3.79e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—BCHE—Alzheimer's disease	1.16e-05	3.76e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-05	3.75e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—Alzheimer's disease	1.15e-05	3.72e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—Alzheimer's disease	1.14e-05	3.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CALM1—Alzheimer's disease	1.13e-05	3.67e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.13e-05	3.67e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—Alzheimer's disease	1.13e-05	3.67e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LEP—Alzheimer's disease	1.13e-05	3.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOE—Alzheimer's disease	1.13e-05	3.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—Alzheimer's disease	1.12e-05	3.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CAV1—Alzheimer's disease	1.12e-05	3.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—Alzheimer's disease	1.11e-05	3.61e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—Alzheimer's disease	1.1e-05	3.58e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	1.09e-05	3.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ESR1—Alzheimer's disease	1.08e-05	3.49e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.08e-05	3.49e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.07e-05	3.48e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.07e-05	3.47e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—F2—Alzheimer's disease	1.06e-05	3.45e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	1.06e-05	3.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.04e-05	3.38e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.04e-05	3.36e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.03e-05	3.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.03e-05	3.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—Alzheimer's disease	1.03e-05	3.35e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	1.02e-05	3.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK8—Alzheimer's disease	1.02e-05	3.31e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	1.02e-05	3.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—Alzheimer's disease	9.91e-06	3.21e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.9e-06	3.21e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GSK3B—Alzheimer's disease	9.77e-06	3.17e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	9.69e-06	3.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CREB1—Alzheimer's disease	9.69e-06	3.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—INS—Alzheimer's disease	9.64e-06	3.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	9.53e-06	3.09e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—Alzheimer's disease	9.52e-06	3.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL2—Alzheimer's disease	9.48e-06	3.08e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—Alzheimer's disease	9.37e-06	3.04e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—LPL—Alzheimer's disease	9.32e-06	3.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IGF1—Alzheimer's disease	9.32e-06	3.02e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	9.2e-06	2.99e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	9.14e-06	2.97e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	9.1e-06	2.95e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CALM1—Alzheimer's disease	9.06e-06	2.94e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOE—Alzheimer's disease	9.02e-06	2.93e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAV1—Alzheimer's disease	8.94e-06	2.9e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	8.92e-06	2.9e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	8.88e-06	2.88e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—Alzheimer's disease	8.71e-06	2.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—Alzheimer's disease	8.58e-06	2.78e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—Alzheimer's disease	8.45e-06	2.74e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	8.4e-06	2.72e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—LPL—Alzheimer's disease	8.32e-06	2.7e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—LPL—Alzheimer's disease	8.12e-06	2.64e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—Alzheimer's disease	8.04e-06	2.61e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	8.01e-06	2.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—Alzheimer's disease	7.98e-06	2.59e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—Alzheimer's disease	7.92e-06	2.57e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.91e-06	2.57e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—Alzheimer's disease	7.86e-06	2.55e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CALM1—Alzheimer's disease	7.84e-06	2.55e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOE—Alzheimer's disease	7.82e-06	2.54e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAV1—Alzheimer's disease	7.74e-06	2.51e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—INS—Alzheimer's disease	7.71e-06	2.5e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	7.5e-06	2.43e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	7.5e-06	2.43e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	7.49e-06	2.43e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.36e-06	2.39e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	7.31e-06	2.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CASP3—Alzheimer's disease	7.18e-06	2.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—Alzheimer's disease	7.13e-06	2.31e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CALM1—Alzheimer's disease	7e-06	2.27e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOE—Alzheimer's disease	6.98e-06	2.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.97e-06	2.26e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAV1—Alzheimer's disease	6.91e-06	2.24e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	6.83e-06	2.22e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOE—Alzheimer's disease	6.81e-06	2.21e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—Alzheimer's disease	6.81e-06	2.21e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—Alzheimer's disease	6.76e-06	2.19e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	6.75e-06	2.19e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—INS—Alzheimer's disease	6.68e-06	2.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK8—Alzheimer's disease	6.59e-06	2.14e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.58e-06	2.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—Alzheimer's disease	6.58e-06	2.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—Alzheimer's disease	6.51e-06	2.11e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.38e-06	2.07e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	6.18e-06	2.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—Alzheimer's disease	6.09e-06	1.98e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—Alzheimer's disease	6.08e-06	1.97e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—Alzheimer's disease	6.01e-06	1.95e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—Alzheimer's disease	6.01e-06	1.95e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—INS—Alzheimer's disease	5.96e-06	1.93e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	5.93e-06	1.92e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—Alzheimer's disease	5.86e-06	1.9e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—INS—Alzheimer's disease	5.82e-06	1.89e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—Alzheimer's disease	5.59e-06	1.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—Alzheimer's disease	5.55e-06	1.8e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.5e-06	1.78e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.47e-06	1.78e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	5.36e-06	1.74e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—Alzheimer's disease	5.23e-06	1.7e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	5.1e-06	1.66e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.01e-06	1.62e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	4.78e-06	1.55e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	4.67e-06	1.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—Alzheimer's disease	4.6e-06	1.49e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.51e-06	1.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—Alzheimer's disease	4.21e-06	1.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.21e-06	1.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.2e-06	1.36e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.16e-06	1.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—Alzheimer's disease	3.88e-06	1.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.65e-06	1.19e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—INS—Alzheimer's disease	3.58e-06	1.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.14e-06	1.02e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—Alzheimer's disease	3.11e-06	1.01e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.87e-06	9.33e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.69e-06	8.73e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—Alzheimer's disease	2.4e-06	7.8e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.35e-06	7.61e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.44e-06	4.69e-06	CbGpPWpGaD
